This topic contains a solution. Click here to go to the answer

Author Question: The extent of an organism's sleep debt is tracked by which of the following structures? a. the ... (Read 42 times)

luminitza

  • Hero Member
  • *****
  • Posts: 555
The extent of an organism's sleep debt is tracked by which of the following structures?
 
  a. the locus coeruleus
 b. the raphe nuclei
 c. the lateral geniculate nucleus
 d. the preoptic area of the hypothalamus

Question 2

The anterior raphe nuclei show the same pattern of activation during states of consciousness as the
 
  a. lateral geniculate nucleus of the thalamus.
 b. preoptic area of the hypothalamus.
 c. locus coeruleus.
 d. pontine reticular formation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kalskdjl1212

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

d

Answer to Question 2

c




luminitza

  • Member
  • Posts: 555
Reply 2 on: Jun 21, 2018
Great answer, keep it coming :)


carlsona147

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Excellent

 

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Dogs have been used in studies to detect various cancers in human subjects. They have been trained to sniff breath samples from humans that were collected by having them breathe into special tubes. These people included 55 lung cancer patients, 31 breast cancer patients, and 83 cancer-free patients. The dogs detected 54 of the 55 lung cancer patients as having cancer, detected 28 of the 31 breast cancer patients, and gave only three false-positive results (detecting cancer in people who didn't have it).

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library